Related Experiment Video
Updated: Aug 16, 2026
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
[In-vitro sensitivity of Klebsiella-Enterobacter strains against cefazolin (author's transl)]
Abstract:
Investigation of the resistance of 290 strains of the Klebsiella-Enterobacter group (252 Klebsiella and 38 Enterobacter strains) against cefazolin showed that 63% of the Enterobacter strains were resistant and 50% of the Klebsiella strains were sensitive both in the serial dilution test and in the agar diffusion test. A total of 78% were inhibited by 32 mug cefazolin per millilitre. Isolates from the genitourinary tract were significantly more resistant than those from the respiratory tract.
Insights
Most Klebsiella-Enterobacter strains show resistance to cefazolin, with genitourinary isolates being more resistant. This highlights challenges in treating infections caused by these common bacteria.
Area of Science:
- Microbiology
- Bacterial resistance
- Antimicrobial agents
Context:
- The Klebsiella-Enterobacter group comprises significant opportunistic pathogens.
- Cefazolin is a widely used cephalosporin antibiotic.
- Antimicrobial resistance is a growing global health concern.
Purpose:
- To investigate the in vitro resistance patterns of Klebsiella and Enterobacter strains against cefazolin.
- To compare cefazolin resistance between different bacterial species within the group.
- To identify potential sources of increased resistance.
Summary:
- A study examined 290 Klebsiella-Enterobacter strains for cefazolin resistance using serial dilution and agar diffusion tests.
- Results indicated significant resistance: 63% of Enterobacter strains and 50% of Klebsiella strains were resistant.
- A high percentage (78%) were inhibited by 32 µg/mL cefazolin, and genitourinary isolates showed higher resistance than respiratory isolates.
Impact:
- Findings suggest potential limitations of cefazolin in treating infections caused by this bacterial group, particularly from genitourinary sources.
- Highlights the need for susceptibility testing to guide appropriate antibiotic selection.
- Informs clinical practice and antimicrobial stewardship efforts for Klebsiella-Enterobacter infections.
More Related Videos
05:06Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
09:22Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
Published on: July 3, 2026